Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg

Verify with FDA CVM →

844 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
844
Total Reports
7
Deaths Reported
80.0%
Death Rate

Active Ingredients

Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg

Administration Routes

OralUnknown

Species Affected

Dog 789
Unknown 48
Human 5
Cat 2

Most Affected Breeds

Chihuahua 160
Terrier - Yorkshire 139
Maltese 91
Unknown 53
Shih Tzu 48
Spitz - German Pomeranian 38
Poodle - Standard 30
Crossbred Canine/dog 29
Dachshund (unspecified) 29
Poodle - Toy 27

Most Reported Reactions

Vomiting 568
Lethargy (see also Central nervous system depression in 'Neurological') 135
Diarrhoea 99
INEFFECTIVE, HEARTWORM LARVAE 58
Lack of efficacy - NOS 35
Underfilling, Package 32
Lack of efficacy (endoparasite) - hookworm 26
Uncoded sign 26
Overdose 26
Shaking 22
Behavioural disorder NOS 22
INEFFECTIVE, ASCARIDS NOS 18

Outcome Breakdown

Recovered/Normal
578 (72.6%)
Outcome Unknown
204 (25.6%)
Recovered with Sequela
4 (0.5%)
Died
4 (0.5%)
Ongoing
3 (0.4%)
Euthanized
3 (0.4%)

Data Summary

Metric Value
Total adverse event reports 844
Reports involving death 7
Case-fatality rate (reported events) 80.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 844 adverse event reports referencing Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg, including 7 reports in which the animal died — a 80.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg reports are Dog (789 reports), Unknown (48 reports), Human (5 reports), with Dog accounting for the largest share. Within those species, Chihuahua (160), Terrier - Yorkshire (139), Maltese (91) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg are Vomiting (568), Lethargy (see also Central nervous system depression in 'Neurological') (135), Diarrhoea (99), INEFFECTIVE, HEARTWORM LARVAE (58). Of the 796 reports with a coded outcome, Recovered/Normal is the leading category at 72.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin 34Mcg, Pyrantel Pamoate 28.5Mg, Praziquantel 28.5Mg.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial